Abraham Van Wyk Email & Phone Number
@quintiles.com
LinkedIn matched
Who is Abraham Van Wyk? Overview
A concise factual answer block for searchers comparing this professional profile.
Abraham Van Wyk is listed as Venture Investor | Technology | Start-up | Life Science Executive at FHI Clinical Inc., a company with 93 employees, based in City Of Cape Town, Western Cape, South Africa. AeroLeads shows a work email signal at quintiles.com and a matched LinkedIn profile for Abraham Van Wyk.
Abraham Van Wyk previously worked as Chief Financial Officer at Fhi Clinical Inc. and Managing Director at Fhi Clinical Inc.. Abraham Van Wyk holds Bsc Hons, Medical Sciences from University Of Pretoria/Universiteit Van Pretoria.
Email format at FHI Clinical Inc.
This section adds company-level context without repeating Abraham Van Wyk's masked contact details.
AeroLeads found 1 current-domain work email signal for Abraham Van Wyk. Compare company email patterns before reaching out.
About Abraham Van Wyk
Passionate about learning & innovation and excited about entrepreneurs brave enough to venture. My experience in life sciences has caused me to gravitate towards opportunities and individuals with exciting visions and clear strategies. I have had the privilege of being involved in R&D in search of solutions for the most daunting challenges, my aim is to maximize learning, and optimize transferring that. Balancing life between operational leadership and early stage investment ensures that from an investment partner we add value beyond financing and aim to allow start-up businesses to continue with their lean and simplified processes. People, partnership and synergy is the why. I am excited about all new ventures and opportunities. I hold a Bachelors of Science In Medical Sciences and a Bachelors of Science in Cellular Biology from the University of Pretoria and a MBA from the University of South Africa.
Listed skills include Clinical Research, Cro, Ctms, Pharmaceutical Industry, and 38 others.
Abraham Van Wyk's current company
Company context helps verify the profile and gives searchers a useful next step.
Abraham Van Wyk work experience
A career timeline built from the work history available for this profile.
Managing Director
CurrentFHI Clinical is a full-service contract research organization (CRO) with the global expertise, responsive approaches and proven solutions to manage complex clinical research around the world. Benefitting from our 50+ year history of clinical research, our team of approximately 450 global staff has worked on studies in nearly 75 countries. As problem.
Co-Founder And Director
CurrentGeneral Partner
CurrentAcquipharma is a boutique investment firm, Acquipharma invests and partners broadly with healthcare companies with interest in in Biotech, Medical Devices, Medical Technologies and Medical Services companies.
Investor And Board Observer
CurrentBUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR)
Partner
CurrentBUGWORKS (www.bugworksresearch.com) is a super exciting start-up drug discovery company, that aims to discover novel treatment options for resistant bacterial infections, and is a spin-off from Cellworks. Bugworks uses highly differentiated Systems Biology approaches to identify novel molecules and resurrect existing antibiotics that have failed owing to.
Co-Founder And Board Member
CurrentLeading a company who has established a network of proficient Software Developers, Clinical Research Experts, Computer System Validation (CSV) specialists and CFR part 11 experts whose technical skills are needed to design all or part of a solid clinical trial. Our uniquely designed solutions allow all the stakeholders within a specialised industry to work.
Partner
CurrentBURL Concepts (www.burlconcept.com) is developing the BURL Device, a portable, battery-powered ultrasound device designed for the non-invasive, transcranial diagnosis of strokes ‘In The Field’. Using disposable ultrasound transducers it works in combination with ultrasound microbubbles. Acoustic response analytic algorithms have been developed to detect.
Board Member
GRI Bio (NASDAQ: GRI) is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune.
Board Member
TCD Outcomes Research (TCD OR) specialises in late phase health outcomes research by studying the real-world value of healthcare solutions and its economic and financial impact. www.tcd-global.com
Board Member
Ceo
TCD is a publicly owned Contract Research Organization based in South Africa. TCD is a emerging markets focussed CRO, with a strong history in drug and device development in Diseases of Neglect as well as vaccine development. www.tcd-global.com
Co-Founder
Associate Director, Region Head
Lecturer
Colleagues at FHI Clinical Inc.
Other employees you can reach at fhiclinical.com. View company contacts for 93 employees →
Kelly O Wami
Colleague at Fhi Clinical Inc.Atlanta, Georgia, United States, United States
View →
CN
Caroldine Neal
Colleague at Fhi Clinical Inc.Stellenbosch, Western Cape, South Africa, South Africa
View →
SB
Sherry Blue
Colleague at Fhi Clinical Inc.Raleigh, North Carolina, United States, United States
View →
LN
Linda Nesbitt
Colleague at Fhi Clinical Inc.Cape Town, Western Cape, South Africa, South Africa
View →
AC
Anita Chaudhary
Colleague at Fhi Clinical Inc.Apex, North Carolina, United States, United States
View →
WM
Wayne Mccullers
Colleague at Fhi Clinical Inc.Raleigh, North Carolina, United States, United States
View →
JL
Joseph Lemao
Colleague at Fhi Clinical Inc.Pretoria, Gauteng, South Africa, South Africa
View →
KF
Kelley Foster
Colleague at Fhi Clinical Inc.Raleigh-Durham-Chapel Hill Area, United States
View →
IV
Itzel Vargas Balderas
Colleague at Fhi Clinical Inc.Mexico City, Mexico, Mexico
View →
GS
George S. Lansana, I
Colleague at Fhi Clinical Inc.Liberia, Liberia
View →
Abraham Van Wyk education
Bsc Hons, Medical Sciences
Bsc, Medical Sciences
Mba, Business Management
Frequently asked questions about Abraham Van Wyk
Quick answers generated from the profile data available on this page.
What company does Abraham Van Wyk work for?
Abraham Van Wyk works for FHI Clinical Inc..
What is Abraham Van Wyk's role at FHI Clinical Inc.?
Abraham Van Wyk is listed as Venture Investor | Technology | Start-up | Life Science Executive at FHI Clinical Inc..
What is Abraham Van Wyk's email address?
AeroLeads has found 1 work email signal at @quintiles.com for Abraham Van Wyk at FHI Clinical Inc..
Where is Abraham Van Wyk based?
Abraham Van Wyk is based in City Of Cape Town, Western Cape, South Africa while working with FHI Clinical Inc..
What companies has Abraham Van Wyk worked for?
Abraham Van Wyk has worked for Fhi Clinical Inc., Metanoia Bio Inc, Acquipharma, Troy Gold, and Bugworks Research Inc..
Who are Abraham Van Wyk's colleagues at FHI Clinical Inc.?
Abraham Van Wyk's colleagues at FHI Clinical Inc. include Kelly O Wami, Caroldine Neal, Sherry Blue, Linda Nesbitt, and Anita Chaudhary.
How can I contact Abraham Van Wyk?
You can use AeroLeads to view verified contact signals for Abraham Van Wyk at FHI Clinical Inc., including work email, phone, and LinkedIn data when available.
What schools did Abraham Van Wyk attend?
Abraham Van Wyk holds Bsc Hons, Medical Sciences from University Of Pretoria/Universiteit Van Pretoria.
What skills is Abraham Van Wyk known for?
Abraham Van Wyk is listed with skills including Clinical Research, Cro, Ctms, Pharmaceutical Industry, Clinical Trials, Clinical Development, Gcp, and Regulatory Submissions.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Abraham Van Wyk you were looking for.
View similar profiles